JCI-accredited partner hospitals

Medical aesthetics · Injectables

Botulinum toxin in China:
approved brands, real timelines, real risks.

Botulinum toxin temporarily relaxes the muscles behind frown lines, crow's feet and forehead lines. It's one of the best-studied aesthetic treatments, and in China it's a prescription drug that must be NMPA-approved and traceable. Counterfeit and unregistered toxin is the main danger.

Quick answer

How long does Botox last, and when does it start working?

In a randomised trial of three toxins, the effect on frown lines began on average within about 2–5 days. For Botox (onabotulinumtoxinA), the peak effect is between 30 and 60 days, and the median duration in the original frown-line studies was 120 days, or about four months. In the pivotal Botox frown-line trial, 5.4% of treated patients had mostly mild eyelid drooping, which is temporary.

~2–5 days

Onset of effect

Mean onset across three toxins, 180 subjects

Rappl et al., 2013

30–60 days

Peak effect

OnabotulinumtoxinA, frown lines

Carruthers et al., 2023 review

120 days

Median duration

Frown lines, initial Botox studies

Carruthers et al., 2023 review

5.4%

Eyelid droop

Mostly mild, 203 treated patients, 20 U

Carruthers et al., JAAD 2002

7

Toxin brands approved in China

January 2026 (press reports)

每日经济新闻, Jan 2026

7.3 million

Toxin treatments worldwide, 2025

The most common non-surgical procedure

ISAPS Global Survey 2025

Common uses

Where toxin is used.

Best studied

Frown lines (glabella)

The approved indication for most products and the one the pivotal trials studied.

Approved indication

Common

Crow's feet & forehead

Widely treated. Forehead doses are balanced against the risk of a heavy or dropped brow.

Product-specific

Often off-label

Jaw (masseter) & others

Jaw slimming, neck bands and sweating are common requests. Some are off-label in China; ask your doctor which product is approved for what.

Ask about labelling

Avoid

'Botox' at a salon

Toxin is a prescription drug in China. Injection outside a medical institution, or with an unregistered product, is illegal and has caused serious harm.

Illegal

Approved brands

Botulinum toxins approved in China

Until 2018 only two toxins were approved in China: the domestic Hengli and Botox. By January 2026, financial press counted seven. The dates below come from company announcements, trade press and one peer-reviewed paper, not from an NMPA register, so check the current status with the hospital.

Botulinum toxin type A products approved in China (as reported)
Brand (Chinese name)Maker / distributorChina approval (source)
Hengli 衡力Lanzhou Institute of Biological ProductsChina's first domestic toxin (press)
Botox 保妥适Allergan / AbbVieMay 2009, frown lines (Scrip)
Dysport 吉适Ipsen / GaldermaJune 2020, 50 U (peer-reviewed phase 3 paper)
Letybo 乐提葆Hugel / SihuanOctober 2020, 100 U (company)
Xeomin 思奥美MerzApproved 2024, launched late 2025 (press)
Daxxify 达希斐Revance / FosunSeptember 2024, 'sixth approved' (press)
RelfydessGaldermaOctober 2026, frown lines (company)

A Huons product distributed by Imeik and a recombinant toxin (Retoxin 芮妥欣) have also been reported; we couldn't confirm their details. Chinese names help you read the box.

Genuine product

How to make sure it's the real thing

Since 2023, botulinum toxin products in China have been covered by a national traceability system. Before the injection, ask to see the sealed box with its Chinese name, batch and traceability code, and have the vial opened in front of you. A hospital department should be happy to record the brand, batch and dose in your notes, so your doctor at home knows exactly what you received.

Antibody-related non-response is uncommon. A meta-analysis of 8,833 patients treated for medical conditions — at higher doses than aesthetic use — found neutralising antibodies in 1.8%, more often with longer treatment. Spacing treatments and avoiding unnecessary top-ups is sensible.

Where to be treated

Hospital departments
that inject toxin.

Shanghai

Huashan Hospital, Fudan University — Dermatology 复旦大学附属华山医院皮肤科

National key specialty; East campus laser centre (since 1974) offers toxin and filler injections

Beijing

Peking Union Medical College Hospital — Dermatology 北京协和医院皮肤科

Dermoscopy, skin ultrasound, Mohs surgery, with laser and cosmetic treatment centres

Shanghai

Shanghai Ninth People's Hospital 上海交通大学医学院附属第九人民医院

Plastic & reconstructive surgery; international department opened January 2024 with a laser cosmetic platform

FAQ

Toxin questions — answered.

Is Hengli the same as Botox?
Both are botulinum toxin type A, but they are different products from different manufacturers, and units are not interchangeable between brands. Your doctor doses each product on its own scale.
What are the common side effects?
Temporary bruising or tenderness at injection points, headache, and occasionally an eyelid or brow droop. In the pivotal frown-line trial, 5.4% of treated patients had mostly mild eyelid droop. These effects wear off as the toxin does.
Can I fly after Botox?
We haven't found good evidence for a fixed waiting time. Many doctors simply advise not rubbing the area or lying flat for a few hours. Ask your doctor; we schedule injections early in the trip so there's time for a check.
How do I know it's not fake?
Be treated in a medical institution, ask to see the sealed box and its traceability code, and confirm the brand is approved in China. Unusually cheap toxin offered outside a hospital is the main warning sign.
Who shouldn't have toxin injections?
People who are pregnant or breastfeeding, those with certain neuromuscular disorders, anyone with an infection at the injection site, or those allergic to the product. Tell your doctor about all your medicines.

Sources

References

  1. 每日经济新闻 (via Eastmoney), 10 January 2026 — seven botulinum toxin products approved in China (Hengli, Botox, Dysport, Letybo, Xeomin, Daxxify, a Huons product); only Hengli and Botox until 2018. Financial press, not an NMPA list.
  2. Scrip. China's State FDA approves Botox for wrinkles (4 May 2009).
  3. Wu Y, Fang F, Lai W, et al. Efficacy and safety of abobotulinumtoxinA for the treatment of glabellar lines in Chinese patients: a pivotal, phase 3 study. Aesthetic Plast Surg. 2023;47(1):351–364.
  4. BioSpectrum Asia. Sihuan receives NMPA approval for exclusive medical aesthetic product Letybo (October 2020).
  5. 华尔街见闻, 10 September 2024 — Fosun Pharma: Daxxify (达希斐) approved by NMPA, the sixth botulinum toxin approved in China.
  6. Galderma. Relfydess receives approval in China for frown lines (press release, October 2026).
  7. NMPA General Department. 药监综药管〔2023〕3号 — national traceability for botulinum toxin products (2023).
  8. Rappl T, et al. Onset and duration of effect of incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA in the treatment of glabellar frown lines: a randomized, double-blind study. Clin Cosmet Investig Dermatol. 2013;6:211–219.
  9. Carruthers J, et al. Treatment of glabellar lines with Botox (onabotulinumtoxinA): development, insights, and impact. Medicine (Baltimore). 2023;102(S1):e32375.
  10. Carruthers JA, Lowe NJ, Menter MA, et al. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol. 2002;46(6):840–849.
  11. Rahman E, Alhitmi HK, Mosahebi A. Immunogenicity to botulinum toxin type A: a systematic review with meta-analysis across therapeutic indications. Aesthet Surg J. 2022;42(1):106–120.
  12. ISAPS Global Survey 2025 (published September 2026) — full report and press releases.

Know the brand and dose
before you're injected.

We arrange toxin treatment at university-hospital departments, with the product name and dose in writing before you book, and recorded in your notes afterwards.

This page is for general education only and is not medical advice. Whether an aesthetic treatment suits you depends on your skin, anatomy, health and goals, and only a qualified doctor who examines you can decide. Trial results describe groups of people, not what will happen to you. We are an independent patient-coordination service; we are not affiliated with any product manufacturer or clinic chain and do not publish treatment prices.

Published 7 November 2026 · Figures checked against the cited sources by the PandaTouring Care editorial team · Editorial policy

Free quote